Pasquale Maria Pecoraro
Overview
Explore the profile of Pasquale Maria Pecoraro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chinchihualpa Paredes N, Pecoraro P, Zaidi S, Duque K, Mahajan A, Mohammad M, et al.
Neurology
. 2025 Feb;
104(6):e213436.
PMID: 40014835
Dopa-responsive dystonia (DRD) encompasses a broad spectrum of phenotypically diverse conditions, offering unique diagnostic challenges. We describe the case of a 24-year-old woman with dystonic gait and jerky position-sensitive limb...
2.
di Biase L, Pecoraro P, Di Lazzaro V
Parkinsonism Relat Disord
. 2025 Feb;
:107326.
PMID: 39952843
Our pathology-validated study on Parkinson's disease aligns with recently reported findings in dementia with Lewy bodies regarding an inverse association with smoking. Understanding this epidemiological relationship is crucial for uncovering...
3.
di Biase L, Pecoraro P, Di Lazzaro V
Ann Neurol
. 2025 Jan;
PMID: 39871110
Objective: Despite diagnostic criteria refinements, Parkinson's disease (PD) clinical diagnosis still suffers from a not satisfying accuracy, with the post-mortem examination as the gold standard for diagnosis. Seminal clinicopathological series...
4.
Ciarrocchi D, Pecoraro P, Zompanti A, Pennazza G, Santonico M, di Biase L
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685917
Since its first introduction, levodopa has remained the cornerstone treatment for Parkinson's disease. However, as the disease advances, the therapeutic window for levodopa narrows, leading to motor complications like fluctuations...
5.
di Biase L, Bonura A, Pecoraro P, Di Lazzaro V
J Stroke Cerebrovasc Dis
. 2024 Dec;
34(2):108173.
PMID: 39643068
Background: Direct Oral Anticoagulants (DOACs) have revolutionized the management of thrombotic conditions, providing more predictable and manageable anticoagulation compared to traditional vitamin K antagonists. Despite their success, major bleeding events...
6.
di Biase L, Pecoraro P, Pecoraro G, Shah S, Di Lazzaro V
J Neurol
. 2024 Aug;
271(10):6452-6470.
PMID: 39143345
Background: The diagnosis of Parkinson's disease is currently based on clinical evaluation. Despite clinical hallmarks, unfortunately, the error rate is still significant. Low in-vivo diagnostic accuracy of clinical evaluation mainly...
7.
di Biase L, Pecoraro P, Carbone S, Alessi F, Di Lazzaro V
Parkinsonism Relat Disord
. 2024 Jun;
125:107022.
PMID: 38865837
Introduction: Epidemiological studies have consistently shown an inverse association between cigarette smoking and Parkinson's disease. Literature indicates that both current and former smokers have a reduced risk of developing PD...
8.
di Biase L, Bonura A, Pecoraro P, Carbone S, Di Lazzaro V
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511304
Stroke, a complex and heterogeneous disease, is a leading cause of morbidity and mortality worldwide. The timely therapeutic intervention significantly impacts patient outcomes, but early stroke diagnosis is challenging due...
9.
di Biase L, Pecoraro P, Carbone S, Caminiti M, Di Lazzaro V
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445461
Since its first introduction, levodopa has become the cornerstone for the treatment of Parkinson's disease and remains the leading therapeutic choice for motor control therapy so far. Unfortunately, the subsequent...
10.
di Biase L, Ricci L, Caminiti M, Pecoraro P, Carbone S, Di Lazzaro V
J Clin Med
. 2023 Feb;
12(4).
PMID: 36835985
Introduction: The present study explores brain connectivity in Parkinson's disease (PD) and in age matched healthy controls (HC), using quantitative EEG analysis, at rest and during a motor tasks. We...